Patents by Inventor Kamilah Apewaiye Gbadamosi

Kamilah Apewaiye Gbadamosi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6517849
    Abstract: This application relates to antiviral tissue paper comprising pyrrolidone carboxylic acid as an antiviral agent. When added to tissue paper pyrrolidone carboxylic acid has the ability to kill certain strains of viruses which come into contact with the tissue. In addition to its antiviral efficacy, pyrrolidone carboxylic acid tends to be mild to the skin thus mitigating the potential for skin irritation. Furthermore, upon transfer to the skin, pyrrolidone carboxylic acid assists in retention of the natural moisture of the skin while continuing to kill deleterious viruses.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: February 11, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Geoffrey Eugene Seger, Kimberly Ann Biedermann, Kamilah Apewaiye Gbadamosi, Stephen Robert Kelly, Paul Thomas Weisman
  • Patent number: 6475501
    Abstract: This application relates to antiviral tissue paper comprising a water soluble metal ion as an antiviral agent. The water soluble metal ion has at least one hydroxide ion formation constant wherein the hydroxide ion formation constant is at least 1012. When added to tissue the water soluble metal ion has the ability to kill certain strains of viruses which come into contact with the tissue.
    Type: Grant
    Filed: October 19, 2000
    Date of Patent: November 5, 2002
    Assignee: The Procter & Gamble Company
    Inventors: Stephen Robert Kelly, Kamilah Apewaiye Gbadamosi, Geoffrey Eugene Seger, Kimberly Ann Biedermann, Jeffrey Michael Morgan, David Frederick Swaile
  • Publication number: 20020064542
    Abstract: A tissue product having an antiviral composition. The antiviral composition includes a film-forming water soluble carrier(s) and one or more antiviral agents. Optional ingredients such as surfactants, thickening agents, dyes, and scents may also be included. The tissue product may include an optional moisture barrier. The moisture barrier may be treated with the antiviral composition. A process for making the tissue product is also disclosed.
    Type: Application
    Filed: June 29, 1999
    Publication date: May 30, 2002
    Inventors: GEORGE ENDEL DECKNER, KAMILAH APEWAIYE GBADAMOSI, STEPHEN ROBERT KELLY, THOMAS JAMES KLOFTA